{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Is Lexaria Bioscience Corp. technically bullish or bearish?
As of April 25, 2025, Lexaria Bioscience Corp. shows a bearish trend with mixed signals from indicators, including a bearish stance from moving averages and KST, despite a mildly bullish weekly MACD and RSI.
What does Lexaria Bioscience Corp. do?
Lexaria Bioscience Corp. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $0 million and a net loss of $3 million as of February 2025, with a market cap of $19.48 million. Key metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -130.81%.
How big is Lexaria Bioscience Corp.?
As of Jun 18, Lexaria Bioscience Corp. has a market capitalization of 19.48 million, with net sales of 0.51 million and a net profit of -9.40 million over the last four quarters. The company's shareholder's funds are 8.04 million, and total assets are 8.87 million as of Aug 24.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
